HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stallwood, Y. Articles by McKenzie, G. J. Search for Related Content PubMed PubMed Citation Articles by Stallwood, Y. Articles by McKenzie, G. J. Pubmed/NCBI databases Substance via MeSH

Small Interfering RNA-Mediated Knockdown of Notch Ligands in Primary CD4⁺ T Cells and Dendritic Cells Enhances Cytokine Production

Lorantis Ltd., Cambridge, United Kingdom

The key interaction in the adaptive immune system’s response to pathogenic challenge occurs at the interface between APCs and T cells. Families of costimulatory and coinhibitory molecules function in association with the cytokine microenvironment to orchestrate appropriate T cell activation programs. Recent data have demonstrated that the Notch receptor and its ligands also function at the APC:T interface. In this study, we describe synthetic small interfering RNA (siRNA) sequences targeting the human Notch ligands Delta1, Jagged1 and Jagged2. Transfection of these siRNAs into human primary CD4⁺ T cells and monocyte-derived dendritic cells leads to knockdown of endogenous Notch ligand message. Knockdown of any one of these three Notch ligands in dendritic cells enhanced IFN- production from allogeneic CD4⁺ T cells in MLR. In contrast, Delta1 knockdown in CD4⁺ T cells selectively enhanced production of IFN-, IL-2, and IL-5 in response to polyclonal stimulation, while Jagged1 or Jagged2 knockdown had no effect. Strikingly, blockade of Notch cleavage with a secretase inhibitor failed to affect cytokine production in this system, implying that Delta1 can influence cytokine production via a Notch cleavage-independent mechanism. These data show for the first time that the Notch pathway can be targeted by siRNA, and that its antagonism may be a unique therapeutic opportunity for immune enhancement.

This article has been cited by other articles:

				W. Gu, M. Cochrane, G. R. Leggatt, E. Payne, A. Choyce, F. Zhou, R. Tindle, and N. A. J. McMillan Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses PNAS, May 19, 2009; 106(20): 8314 - 8319. [Abstract] [Full Text] [PDF]

				X.-L. Zhang, J. Peng, J.-Z. Sun, J.-J. Liu, C.-S. Guo, Z.-G. Wang, Y. Yu, Y. Shi, P. Qin, S.-G. Li, et al. De novo induction of platelet-specific CD4+CD25+ regulatory T cells from CD4+CD25- cells in patients with idiopathic thrombocytopenic purpura Blood, March 12, 2009; 113(11): 2568 - 2577. [Abstract] [Full Text] [PDF]

				N. Asano, T. Watanabe, A. Kitani, I. J. Fuss, and W. Strober Notch1 Signaling and Regulatory T Cell Function J. Immunol., March 1, 2008; 180(5): 2796 - 2804. [Abstract] [Full Text] [PDF]

				E. Ortega-Paino, J. Fransson, S. Ek, and C. A. K. Borrebaeck Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference Blood, February 1, 2008; 111(3): 1617 - 1624. [Abstract] [Full Text] [PDF]

				A. M. Kostianovsky, L. M. Maier, C. Baecher-Allan, A. C. Anderson, and D. E. Anderson Up-Regulation of Gene Related to Anergy in Lymphocytes Is Associated with Notch-Mediated Human T Cell Suppression J. Immunol., May 15, 2007; 178(10): 6158 - 6163. [Abstract] [Full Text] [PDF]